Piracetam: The First Racetam, Judged by Its Trials
Piracetam started the racetam family in the 1960s and has been tested in people for dementia, stroke, aphasia, myoclonus and more. Pooled, those trials are mixed: a strong signal for a few conditions, little for memory, and almost nothing on healthy people.
Build your own printable peptide tracker
A personalized injection log, weekly dosing schedule and dated calendar: your compounds filled in, ready to print. Free to build and preview; $5/month to unlock printing.
How Does Piracetam Work?
A 1994 review of 407 papers found no affinity for adrenergic, muscarinic, serotonin, dopamine, adenosine, opiate, GABA, benzodiazepine or glutamate receptors. The authors concluded no generally accepted mechanism had emerged, and proposed that racetams amplify neurotransmission already under way, possibly through ion flux.
A 2005 review describes piracetam as a derivative of the neurotransmitter GABA whose effects may come partly from restoring cell membrane fluidity. At the neuron level it modulates several transmitter systems, including cholinergic and glutamatergic ones, and it has anticonvulsant properties.
Piracetam inhibits platelet aggregation and shows antithrombotic activity in vivo (Evers 1999). The 2005 review adds that it appears to reduce red blood cell adhesion to vessel walls and to facilitate microcirculation. Those vascular effects are part of why it was tested in stroke. For sickle cell disease the rationale was lab work showing it can inhibit red cell sickling (Cochrane 2016).
UCB Pharma marketed most of the world's piracetam, according to the Cochrane dementia review. Its clearest clinical role is cortical myoclonus, where reviewers called it a first-line drug; in two double-blind trials, individual dose needs ranged from 7 to 24 g a day (Genton 1999).
What the Data Shows
Key Takeaways
- A 2001 Cochrane review found better clinician global impression scores with piracetam in dementia or cognitive impairment, but no benefit on any more specific measure, and did not support its use (PMID 11405971).
- A 2024 meta-analysis of 18 studies and 886 adults with memory impairment found no significant memory effect (PMID 38878641).
- In acute ischaemic stroke, a Cochrane review of 1002 patients found no difference in function and a non-significant rise in early death (PMID 22972044).
- For post-stroke aphasia, 7 trials showed better written language but no significant change in overall severity (PMID 27236454).
- In children with breath-holding spells, 5 trials found more responders than placebo, with similar rates of side effects (PMID 39692893).
- Reviewers of cortical myoclonus called it a first-line drug with good long-term tolerability; individual dose needs in two double-blind trials ranged from 7 to 24 g a day (PMID 10338109).
- Whether it sharpens healthy brains. A 2022 review called the efficacy of cognitive enhancers in healthy people uncertain (PMID 35366192).
- How it works. A 1994 review of the literature from 1965 to 1992 found that no generally accepted mechanism had emerged (PMID 8061686).
- Whether any benefit lasts. The Cochrane reviewers asked for trials of at least 6 months using modern diagnostic criteria (PMID 11405971).
- How it combines with blood thinners. It inhibits platelet aggregation (PMID 10338108), and none of the reviews here tested it alongside anticoagulants.
- Whether the early-death signal in stroke was real. The Cochrane authors think stroke-severity imbalance may explain it (PMID 22972044).
Frequently Asked Questions
What is piracetam?
Piracetam is the original racetam nootropic, discovered in the 1960s (PMID 8061686). A 2005 review describes it as a derivative of the neurotransmitter GABA (PMID 16007238). UCB Pharma marketed most of the world supply as a prescription drug (PMID 11405971), and its clearest medical use is cortical myoclonus.
Does piracetam improve memory?
Not clearly. A 2024 meta-analysis of 18 studies in 886 adults with memory impairment found no significant memory effect (PMID 38878641). The 2001 Cochrane review saw better clinician global impression scores but no gain on specific cognitive measures, and concluded the evidence did not support its use for dementia (PMID 11405971).
Does piracetam work for healthy people?
Nobody has shown it. The human trials summarised on this page enrolled patients with a condition, such as dementia, stroke or myoclonus. A 2022 review of smart drugs in healthy people judged their efficacy uncertain and any reported improvement temporary (PMID 35366192). Results in impaired brains do not transfer automatically.
Is piracetam safe?
Its safety record in trials is good. A 1994 review called racetam toxicity very low with no serious side effects (PMID 8061686), and myoclonus patients have taken high doses for years (PMID 10338109). Two cautions: it inhibits platelet aggregation (PMID 10338108), and a stroke review saw a non-significant rise in early death (PMID 22972044).
How does piracetam compare with other racetams?
Piracetam is the parent compound. Later relatives such as oxiracetam, pramiracetam and aniracetam share its lack of receptor binding (PMID 8061686). Sunifiram, a piperazine compound structurally related to piracetam, was about 1,000 times more potent than piracetam-like drugs in mice (PMID 12070754). See our racetam and sunifiram guides for those compounds.
Buy Piracetam (Research Grade)
Swiss Chems publishes third-party HPLC COAs for selected products (vendor-published, a claim to verify). Deep-linked to the Piracetam product page.
Buy Piracetam at Swiss Chems →Affiliate links support HighPeptides at no extra cost.
Recommended Products
Choline sources and other nootropics sold on Amazon, each covered in its own guide. Piracetam itself is linked above.
Affiliate links support HighPeptides at no extra cost.
Related HighPeptides Research
Peer-Reviewed References
67-page guide: protocols, dosing, sourcing. Everything in one place.
Get the guide: $19 (normally $29) → The Protocol & Stack Handbook ($19) All ebooks & guides →Educational purposes only. Not medical advice.
Piracetam is a prescription medicine in some countries. Talk to a clinician before using it, especially if you take blood thinners.
Get the Free 2026 Peptide Protocol Stack
Twelve compounds across four pillars: metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.